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Abstract
Introduction: Therapeutic hypothermia is largely used to protect the brain following return of spontaneous
circulation (ROSC) after cardiac arrest (CA), but it is unclear whether we should start therapeutic hypothermia
earlier, that is, before ROSC.
Methods: We performed a systematic search of PubMed, EMBASE, CINAHL, the Cochrane Library and Ovid/Medline
databases using “arrest” OR “cardiac arrest” OR “heart arrest” AND “hypothermia” OR “therapeutic hypothermia” OR
“cooling” as keywords. Only studies using intra-arrest therapeutic hypothermia (IATH) were selected for this review.
Three authors independently assessed the validity of included studies and extracted data regarding characteristics
of the studied cohort (animal or human) and the main outcomes related to the use of IATH: Mortality, neurological
status and cardiac function (particularly, rate of ROSC).
Results: A total of 23 animal studies (level of evidence (LOE) 5) and five human studies, including one randomized
controlled trial (LOE 1), one retrospective and one prospective controlled study (LOE 3), and two prospective
studies without a control group (LOE 4), were identified. IATH improved survival and neurological outcomes when
compared to normothermia and/or hypothermia after ROSC. IATH was also associated with improved ROSC rates
and with improved cardiac function, including better left ventricular function, and reduced myocardial infarct size,
when compared to normothermia.
Conclusions: IATH improves survival and neurological outcome when compared to normothermia and/or
conventional hypothermia in experimental models of CA. Clinical data on the efficacy of IATH remain limited.
Introduction
Use of mild therapeutic hypothermia, or “targeted tem-
perature management” as recently suggested [1], has
been recommended in cardiac arrest (CA) patients since
the publication of two randomized clinical trials in 2002,
the results of which demonstrated a significant improve-
ment in neurologically intact survival for comatose CA
patients presenting with ventricular fibrillation (VF) or
ventricular tachycardia (VT) [2,3]. Current guidelines
suggest that mild therapeutic hypothermia should also be
considered in patients presenting with other rhythms
although this has been less well studied [4].
Although therapeutic hypothermia has been widely
implemented [5], its benefits are still questioned and
several issues remain unanswered, including the optimal
time to initiate cooling. Animal data have indicated that
early cooling after return of spontaneous circulation
(ROSC) produces better brain function and neurological
recovery than does normothermia, whereas delaying
therapeutic hypothermia significantly limited these bene-
ficial effects [6,7]. There are also experimental data sug-
gesting that hypothermia initiated during
cardiopulmonary resuscitation (CPR), that is, intra-
arrest, is superior to cooling initiated after ROSC, both
in terms of increased rates of successful CPR and
improved survival [8-11]. Experimental investigations
have also shown that intra-arrest therapeutic hypother-
mia (IATH) increases the success rate of defibrillation
attempts in VF [12] and has beneficial effects on heart
function, including improved left ventricular function
and reduced myocardial infarct size [13]. Clinical inves-
tigations have shown that pre-hospital induction of
* Correspondence: jlvincen@ulb.ac.be
1Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles,
Route de Lennik 808, 1070 Brussels, Belgium
Full list of author information is available at the end of the article
Scolletta et al. Critical Care 2012, 16:R41
http://ccforum.com/content/16/2/R41
© 2012 Scolletta et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
therapeutic hypothermia is feasible [14], without major
adverse events even when used intra-arrest [15], and
may provide some additional benefits over delayed in-
hospital cooling [16].
The objective of this systematic review of the litera-
ture was, therefore, to evaluate whether IATH affects
survival and neurological and cardiac function in experi-
mental and human CA.
Materials and methods
Search strategy
The following databases were searched up to 30 July
2011: PubMed (from 1966), EMBASE (from 1974),
CINAHL (from 1982), the Cochrane Library (from 1974)
and Ovid/Medline (from 1966). The search strategy used
the following terms: “arrest” OR “cardiac arrest” OR
“heart arrest” AND “hypothermia” OR “therapeutic
hypothermia” OR “cooling”. References from identified
studies and relevant review articles were also searched
for additional eligible citations. The search was limited to
English publications and was conducted in accordance
with the International Liaison Committee on Resuscita-
tion (ILCOR) process of evidence evaluation [17].
Study selection
Two authors (KD and FST) independently reviewed cita-
tions, abstracts and full-text articles to select eligible
studies. We excluded: a) review articles; b) case reports;
c) experimental studies other than animal studies (for
example, cell culture, isolated organs); d) studies focus-
ing on induced circulatory arrest (for example, for aortic
arch surgery). During the selection process, we included
all studies in which hypothermia was initiated before
ROSC (that is, during CA); we then excluded studies in
which IATH was not used alone (for example, together
with cardiopulmonary bypass (CPB)). In case of dis-
agreement, the eligibility of an article was decided by
consensus among all authors (step 1).
For animal studies, we restricted studies to those that
included a control group (either treated with nor-
mothermia or by conventional therapeutic hypothermia,
that is, post-arrest therapeutic hypothermia (PATH), or
another IATH group) and reported at least one of the
following outcomes: a) overall mortality; b) brain func-
tion (neurological status, cerebral perfusion and/or
metabolism); b) heart function (for example, rate of
ROSC, characteristics of CPR, cardiac perfusion and
performance) (step 2).
Data abstraction and study quality
For each eligible study, two authors (SS and FST) inde-
pendently abstracted data regarding: a) study design; b)
characteristics of the study population; c) sample size; d)
outcome measurements; and e) study quality. No attempt
was made to re-analyze the data. Studies were classified
by level of evidence (LOE) for studies with therapeutic
interventions (Table 1) and quality (poor, fair or good)
according to published definitions (step 3) [17]. Inter-
observer agreement was calculated using percent agree-
ment and the kappa statistic. The percent of agreement
(kappa statistic) for each stage of selection was: step 1 =
89% (k, 0.87); step 2, 98% (k, 0.96); step 3 = 100% (k = 1).
Review end-points
The end-points of this study were to answer the follow-
ing questions related to the use of IATH from the exist-
ing evidence:
1) What are the effects on mortality, brain and heart
functions?
2) How should IATH be induced?
3) What are the potential adverse events?
Results
Search results
The search retrieved a total of 17,628 citations (Figure 1).
After application of the selection criteria, 28 articles were
eligible for data abstraction: 23 were on experimental CA
(LOE 5) and 5 on human CA (number of patients = 808).
Among the clinical studies, one was a randomized con-
trolled trial (RCT, LOE 1) [16], one a retrospective [18]
and one a prospective [19] controlled study (LOE 3), and
two were prospective studies without a control group
(LOE 4) [15,20] (Table 2). Table 3 shows RCTs on IATH
that are ongoing in the clinical setting. The characteris-
tics of the included studies are shown in Tables 4, 5, 6.
Effects on mortality
Sixteen animal and three human studies reported data
on mortality.
a) IATH versus normothermia
Nine animal studies reported similar mortality rates in
IATH and normothermia groups [6,10,12,21-26], and
seven animal studies reported an improvement in survi-
val rate in IATH-treated animals [8,27-32].
In an early human trial, external cranial IATH was
investigated in 22 patients during out-of-hospital cardiac
arrest (OHCA) [19], including 9 who received cranial
cooling and 13 who did not; no patients survived to
hospital discharge. A recent retrospective study com-
pared the outcome of 208 OHCA patients treated with
intra-arrest cold intravenous fluids to historical controls
(n = 334) [18]. The use of IATH was not associated
with increased overall survival to hospital admission
(28% vs. 23%) or to discharge (13% vs. 12%).
b) IATH versus PATH
Two experimental studies reported improved survival
with early IATH [8,13] and four [6,24,29,30] found no
differences in mortality.
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In the only RCT using IATH [16], OHCA patients
were randomized, irrespective of their rhythm, to receive
either trans-nasal evaporative cooling (TNEC, n = 96) or
standard of care (n = 104, including PATH) during
CPR. Overall survival rates were similar in the two
groups (15% vs. 13%). Among patients admitted to the
hospital, overall survival was increased, although not sig-
nificantly, from 31 to 44% using IATH (P = 0.16). In the
post hoc analysis, the sub-group of patients with time to
CPR less than 10 minutes had an increased survival rate
when treated by IATH (56% vs. 29%, P = 0.04). A non-
significant 15% improvement in the survival rate was
also observed in the small subgroup of VF patients.
Effects on neurological outcome
Ten animal studies and one human study reported data
on neurological outcomes.
a) IATH versus normothermia
In five studies, more animals in the intra-arrest cooling
group had a good neurological outcome compared to
normothermic animals [6,8,24,27,28]. In six studies, the
neurological deficit score (NDS, where a score of 0 indi-
cates no neurological deficit) was significantly lower in
IATH than in normothermic animals [6,21,24,26,29,31].
Only two animal studies reported that IATH did not
result in a better neurological outcome: In the first, all
animals survived without neurological deficit at seen
Table 1 ILCOR levels of evidence for therapeutic interventions
LOE 1 Randomized controlled trials (RCTs) or meta-analyses of RCTs
LOE 2 Studies using concurrent controls without true randomization or meta-analyses of such studies
LOE 3 Studies using retrospective controls
LOE 4 Studies without a control group (for example, cases series)
LOE 5 Studies not directly related to the speciﬁc population (for example, different patients, animal models, mechanical models, and so on)
Figure 1 Flow diagram of study selection process.
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days after CA [23]; in the other, there were no differ-
ences in neurological outcome in terms of overall per-
formance categories (OPC, 1 and 2 being good
neurological outcome) or histological damage score
(HDS) between IATH and normothermia groups [21].
Nevertheless, the percentage of injured neurons or the
NDS was significantly lower in the IATH group com-
pared with the normothermic group in these two studies
[21,23].
b) IATH versus PATH
One experimental study [8] found a significant improve-
ment in neurological status in animals treated with
IATH compared to PATH, and another [24] showed a
larger, although not statistically significant, number of
animals with intact brain function in the IATH group.
In a human RCT, TNEC increased, although not signif-
icantly (P = 0.14), the intact neurological outcome rate
from 21% to 34% when compared to a control group of
patients admitted to hospital and cooled after CA [16];
these beneficial effects were more pronounced in patients
with short time to CPR (43% vs. 17%, P = 0.03).
Effects on brain perfusion and metabolism
Six animal studies reported data on brain perfusion and
metabolism [6,22,23,25,33,34]. No human study has
reported data on cerebral perfusion and/or metabolism
during IATH.
a) IATH versus normothermia
Cerebral perfusion pressure (CPP) did not differ signifi-
cantly between IATH and normothermia groups when
selective brain cooling [23,33] or a combination of cold
intravenous solutions and external cooling [6] were
used. Cerebral blood flow (CBF) and cerebral oxygen
extraction rate were similar during CPR and after ROSC
in IATH and in normothermic animals [22,33]. Never-
theless, during CPR, hypothermic animals had higher
blood flow in the caudate nucleus and the infra-tentorial
regions than did normothermic animals [33], and cere-
bral oxygen uptake was significantly lower in hypother-
mic animals (44 vs. 69%, P = 0.02) at 45 minutes after
reperfusion [33]. In a canine VF model of CA, IATH
prevented the decrease in supratentorial blood flow and
cerebral metabolic rate occurring during CPR at a CPP
of 25 mmHg [34]. In another study, nasopharyngeal
IATH resulted in a longer duration of high CBF at
reperfusion when compared to normothermia [23]. Pigs
treated with intra-arrest cooling had significantly higher
values of venous jugular bulb saturation (SjO2), a surro-
gate for CBF, although CPP was similar during the
study period [25]. Finally, cerebral metabolism was pre-
served during intra-arrest cooling as IATH prevented
secondary increases in the lactate/pyruvate ratio (LPR)
and glutamate levels when compared to normothermia
[25].
b) IATH versus PATH
Only one animal study has reported data on brain per-
fusion and metabolism [6]: CPP was similar in IATH
and PATH groups.
Effects on cardiac function
Four animal studies have reported data on cardiac func-
tion [13,27,30,31]. No human study has specifically
investigated heart function after CA when IATH therapy
was used.
a) IATH versus normothermia
Left ventricular ejection fraction (LVEF) after CA was
significantly increased by IATH compared to nor-
mothermia [13,30,31]. The ratio of infarction size to LV
Table 2 Evidence on intra-arrest hypothermia for human cardiac arrest
Quality of Evidence Good ** Castrén, ABCD
* Castrén, E
Fair
Poor * Garrett, A
** Garrett, BCD * Bruel, E
** Callaway, E * Kämärainen, E
1 2 3 4 5
Level of Evidence
Outcomes: A, return of spontaneous circulation; B, survival of event; C, survival to hospital discharge; D, intact neurological survival; E, reduction in temperature.
Evidence, * supporting; ** neutral; *** opposing
Table 3 Ongoing clinical trials on intra-arrest therapeutic hypothermia in cardiac arrest
STATUS NCT STUDY
Active, recruiting NCT01400373 PRINCESS: Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study
Active, recruiting NCT00886184 HITUPPAC-BIO: Intra-arrest therapeutic hypothermia in pre-hospital cardiac arrest
Active, recruiting NCT01413399 A pilot study of intra-arrest hypothermia in patients suffering non-traumatic out-of-hospital cardiac arrest
Active, recruiting NCT01173393 Rapid Infusion of Cold Normal Saline During CPR for Patients With Non-VF Out-of-hospital Cardiac Arrest (RINSE)
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Species N Arrest Rhythm No-
flow
(min)






Abella [8] Survival (%, 3 days) 60 10* 10* Mice 30 KCl NA 8 Ice-water blanket 30 10 to 11
GNO (%, 3 days) 60 10* 10*
ROSC (%) 100 100 100
Albaghdadi
[35]
ROSC (%) 78 45 Pigs 20 Asphyxia NA 5 PFC-TLV 36 11 to 13
CoPP (mmHg) 14 14
Boddicker
[28]
Survival (%, 24 hrs) 87 0* Pigs 32 EC VF 8 Surrounding the
body with ice
33 12 to 18
GNO (%, 24 hrs) 87 0*
ROSC (%) 87 0*
CoPP (mmHg) 15 10
Menegazzi
[12]
Survival (%, 20 min) 57 36 Pigs 28 EC VF 8 ivfluid 34 13
ROSC (%) 86 43*
CoPP (mmHg) 10 11
Nordmark
[22]
Survival (3-hrs) 80 100 Pigs 20 EC VF 8 ivfluid 36 15 to 20
ROSC (%) 90 100
Nordmark
[25]
Survival (%, 6 hrs) 100 100 Pigs 16 EC VF 8 ivfluid 33 17
LPR > 30 (n) 29 88*
SjO2 (%, 6 hr) 100 78*
ROSC (%) 100 100
Riter [10] Survival (%, 1 hr) 100 100 Pigs 24 EC VF 11 PFC-TLV 35 22
ROSC (%) 88 12*
CoPP (mmHg) 14 10
Shaffner [34] CBF (mL/100 g/min) 10 5* Dogs 12 EC VF 6 Ice 28 NA
Staffey [15] ROSC (%) 82 27* Pigs 33 EC VF 11 PFC-TLV 33 22
CoPP (mmHg) 10 10
Sterz [6] Survival (%, 3 days) 75 92 84 Dogs 36 EC VF 10 Cold iv fluids 34 16 to 20
GNO (%, 3 days) 50 8* 41 External cooling
NDS (3 days) 19 36* 22
CPP (mmHg) 55 50 51
ROSC (%) 75 92 84
CoPP (mmHg) 42 48 43
Xiao [24] Survival (%, 3 days) 100 100 100 Rats 30 Asphyxia NA 5 Ice water 34 7
GNO (%, 3 days) 100 40* 80
NDS (3 days) 1 20* 12*
ROSC (%) 100 100 100
Yannopoulos
[13]
ROSC (%) 100 66* 44 Pigs 45 CVO VF 5 Intravascular
catheter
33 20
CoPP (mmHg) 21 21 20
LVEF (%) 32 23* 21*
Zhao [27] Survival (%, 7 days) 53 0* Mice 45 KCl NA 8 Blankets 30 10 to 11
GNO (%, 3 days) 66 0*
ROSC (%) 93 80
dP/dtmax (mmHg/s) 6000 3800*
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weight, a surrogate of degree of ischemic damage after
coronary occlusion, was also noted to be significantly
reduced by IATH when compared to normothermia
[13]. Cardiac function evaluated by pressure-volume
loops showed that early IATH resulted in improved car-
diac output and contractility when compared to nor-
mothermia [27]. In another study, systolic and diastolic
functions were both improved by cooling and the
beneficial effects were more significant when hypother-
mia was initiated during CPR [31].
b) IATH versus PATH
In one animal study, cardiac function during IATH was
compared to that during PATH [30]. Both IATH and
PATH improved post-resuscitation myocardial dysfunc-
tion, but the beneficial effects were greatest with IATH
[30]. In a second study, Yannopoulos et al. showed that
Table 4 Summary of animal trials on intra-arrest hypothermia during cardiac arrest according to method of cooling
(Continued)
SELECTIVE BRAIN COOLING
Brader [26] Survival (24 hrs) 33 0 Dogs 12 EC VF 4 Ice bags around
the head
36 24
NDS (24 hrs) 37 62*
ROSC (%) 82 82
Cho [32] Survival (hrs) 9.3 0.1* Pigs 16 EC VF/PEA 14 TNEC 36 to 37 19 to 29
ROSC (%) 75 12*
CoPP (mmHg) 25 14*




CBF (mL/100 g/min) 16 18




Guan [29] Survival (%, 4-days) 100 29* 86 Pigs 24 EC VF 10 TNEC 34-35 15 to 25
NDS (4-days) 0 400* 0
Hagioka [23] Survival (%, 7-days) 100 100 Rats 14 CVO VF 5 NFC 37 6
GNO (%, 7-days) 100 100
CPP (mmHg) 40 34
HDS 33 71*
Jeung [21] Survival (%, 3 days) 72 72 Dogs 14 EC VF 9 CF 35 12 to 15
NDS (3 days) 18 42*
ROSC (%) 100 100
Tsai [30] Survival (%, 4 days) 100 25* 63 Pigs 24 EC VF 10 TNEC 34 15 to 25
ROSC (%) 100 88 88
CoPP (mmHg) 21 18 20
LVEF (%) 63 52* 51*
Tsai [31] Survival (%, 4 days) 100 29* Pigs 16 EC VF 10 TNEC 34 15 to 25
NDS (%, 4 days) 0 400*
ROSC (%) 100 88
CoPP (mmHg) 21 18
LVEF (%) 63 53*
Wang [36] ROSC (%) 87 25* Pigs 16 EC VF 15 TNEC 34 20 to 30
CoPP (mmHg) 25 16*
CBF, cerebral blood flow; CF, carotid flush with cold saline fluids; CG, control group; CoPP, coronary perfusion pressure; CPP, cerebral perfusion pressure; CVO,
coronary vascular occlusion; dP/dt, pressure/time ratio; EC, electrical current; GNO, good neurological outcome; HDS, histological deficit score; HT, hypothermia;
IATH intra-arrest therapeutic hypothermia; KCl, potassium chloride; KT, catheter; LPR, lactate/pyruvate ratio; LVEF, left ventricular ejection fraction: MBF,
myocardial blood flow; N, number; NA, not available; NDS, neurological deficit score; NFC, nasoparhyngeal cooling (saline); NT, normothermia; PATH, conventional
(post-arrest) hypothermia; PFC-TLV, perfluorocarbon-based total liquid ventilation; ROSC, return of spontaneous circulation; SjO2, jugular bulb venous oxygen
saturation; TNEC, trans-nasal evaporative cooling; VF, ventricular fibrillation; *, P < 0.05 vs. IATH
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intra-arrest cooling significantly improved LVEF and
reduced the ischemic myocardial damage compared to
delayed cooling [13].
Effects on coronary perfusion pressure
Twelve animal studies reported data on coronary perfu-
sion pressure (CoPP), defined as the difference between
diastolic arterial pressure and central venous pressure,
during CPR [6,10-13,28,30-33,35,36]. No human study
has reported data on CoPP during IATH.
a) IATH versus normothermia
Ten studies showed that CoPP did not differ signifi-
cantly between IATH and normothermia groups when
different types of cooling were used
[6,10-13,28,30,31,33,35]. One study reported a higher
CoPP in the IATH group during the first three minutes
of CPR, but not thereafter [10]. Two studies reported a
higher CoPP before defibrillation when intra-arrest cool-
ing was initiated using TNEC, compared to control nor-
mothermic animals [32,36].
b) IATH versus PATH
Three animal studies reported a similar CoPP in animals
treated with IATH and those treated with PATH
[6,13,30].
Effects on return of spontaneous circulation (ROSC)
Eighteen animal studies
[6,8,10-13,21,22,24-28,30-32,35,36] and three human
studies [16,18,19] reported data on ROSC rate.
a) IATH versus normothermia
Ten experimental studies found no difference in ROSC
rate between IATH and normothermia
[6,8,21,22,24-27,30,31]. Albahgdadi et al. found a non-
significant improvement in ROSC success with sponta-
neous circulation achieved in 78% of IATH and 45% of
normothermic animals (P = 0.2) [35]. Seven animal stu-
dies reported an increase in ROSC rate with IATH
[10-13,28,32,36].
In two clinical studies, IATH was associated with an
increased ROSC rate compared to normothermia
[18,19].
b) IATH versus PATH
Four experimental studies found no difference in ROSC
rate between IATH and PATH [6,8,24,30]. One animal
Table 5 Summary of animal trials that used different
methods to induce intra-arrest hypothermia during
cardiac arrest.
Outcome IATH (%) IATH
(%)
Riter [10] PFC-TLV iv fluids
Survival (1-hr, %) 100 100
ROSC (%) 88 25






ROSC (%) 100 55 *
CoPP (mmHg) 21 15 *
LVEF (%) 32 17 *




ROSC (%) 100 29 *
CoPP (mmHg) 23 12 *
CoPP, coronary perfusion pressure; LVEF, left ventricular ejection fraction; PFC-
TLV, perfluorocarbon-based total liquid ventilation; ROSC, return of
spontaneous circulation; TNEC, trans-nasal evaporative cooling; *, P < 0.05
Table 6 Summary of clinical trials on intra-arrest hypothermia (IATH) during cardiac arrest


























Bruel [15] OHCA Cold iv
fluids





17 N 59 -1.34°C NA 71% 64% 6% 9%


















Garrett [18] OHCA Cold iv
fluids










Δt, difference in temperature; CTRL, control group; iv, intravenous; NA, not applicable/available; N, no; NS, not significant; NT, normothermia; OHCA, out-of-
hospital cardiac arrest; PATH, conventional (post-arrest) hypothermia; Pts., patients; ROSC, return of spontaneous circulation; tymp, tympanic; VF, ventricular
fibrillation; VT, ventricular tachycardia; Y, yes
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study noted that the ROSC rate was increased with
IATH when compared to PATH [13]. In the human
RCT using intra-arrest TNEC [16], patients receiving
IATH had similar ROSC rates compared to the control
group (38% vs. 43%).
Effects on defibrillation attempts and epinephrine dose
Eleven animal studies reported data on the effects of
IATH on duration and characteristics of CPR
[6,10-13,21,28,30-32,36]. No human studies have specifi-
cally reported data on duration and characteristics of
CPR during IATH.
a) IATH versus normothermia
In one study, there were no significant differences in the
duration of CPR, the total dose of epinephrine adminis-
tered during CPR or the number of counter-shocks
given to reverse VF between animals that received
IATH and those that remained normothermic [21]. Two
other studies also found no difference in the number of
defibrillation shocks required to achieve ROSC [10,32].
Sterz et al. [6] showed no differences in requirements of
counter-shocks and the dose of epinephrine or in the
duration of CPR between IATH- and normothermia-
treated animals.
Seven animal studies reported variable effects of IATH
on duration and characteristics of CPR [11-13,28,30,
31,36]. In one, a somewhat smaller number of counter-
shocks was required to achieve ROSC in IATH when
compared to normothermia (9 vs. 17, P = 0.07) but the
total dose of epinephrine required was lower as was the
duration of CPR [31]. Tsai et al. reported that fewer
defibrillation shocks were required to achieve ROSC in
IATH compared to normothermia [30]; the total dose of
epinephrine required to achieve ROSC was also lower in
IATH as was the duration of CPR. In two studies, IATH
achieved ROSC with a lower number of shocks but had
a similar success rate as the normothermic group for
initial shocks [11,12]. In a porcine model, the total
amount of epinephrine used during the recovery period
was three times less in the IATH than in the nor-
mothermia group [12]; however, the total number of
defibrillation attempts did not differ between groups
[11,12]. In another porcine model, there was no signifi-
cant difference in the number of shocks needed (7 vs.
6.9) or in the success rate of initial shocks between
IATH and normothermic animals (50 vs. 12%), but the
duration of CPR was shorter in the IATH group [36].
Boddicker et al. reported that the first defibrillation was
successful in 12% of normothermic compared to 75% of
moderately cooled IATH animals (P = 0.04) [28]; the
total number of delivered shocks was lower in IATH
than in normothermic animals as was the number of re-
fibrillations. Finally, Yannopoulos et al. reported that
IATH was associated with fewer shocks to first ROSC,
fewer total shocks and doses of epinephrine, and a
shorter duration of CPR compared to normothermia
[13]. No human studies have specifically reported data
on duration and characteristics of CPR during IATH.
b) IATH versus PATH
Sterz et al. [10] showed no differences in requirements
of counter-shocks and the dose of epinephrine or in the
duration of CPR between IATH- and PATH-treated ani-
mals. In another study, IATH was associated with fewer
shocks to first ROSC, fewer total shocks and doses of
epinephrine, and a shorter duration of CPR compared
to PATH [13].
Effects of methods of inducing IATH
In animal studies, IATH has been induced by various
techniques/devices, including ice packs, intravascular
catheters, cold metal plates or total lung ventilation with
perfluorocarbon (PFC). Some devices selectively cool the
brain without affecting core body temperature. Few stu-
dies have compared the effects of these different devices
on outcomes.
a) Effects of IATH method on outcomes
Three studies reported the effects of different types of
IATH induction on mortality, brain or cardiac function
after CA [10,13,37] (Table 5). LVEF was significantly
increased by IATH induced by an intravascular system
compared to intra-arrest cold fluids [13]; IATH using
cold fluids resulted in a lower CoPP, a greater need for
epinephrine and a longer duration of CPR. In a study by
Riter et al. [10], cold fluids and PFC-TLV rapidly
achieved target temperature, but ROSC was achieved
more easily with PFC-TLV. In a model of prolonged
CA, TNEC initiated during CPR improved the success
of resuscitation compared with IATH induced by cold
fluids; however, no difference in the survival rate was
found [37]. The total number of countershocks and
amount of epinephrine administered to achieve ROSC
was significantly lower with IATH-TNEC than with cold
fluids; the duration of CPR was also significantly
reduced and CoPP higher when TNEC was used.
b) Effects of time of initiation of IATH
One experimental study investigated the role of early
versus delayed induction of IATH [27]. Early IATH sig-
nificantly improved survival and intact neurological out-
come when compared to delayed IATH and was
associated with improved cardiac output and contracti-
lity (evaluated by pressure-volume loops) [27].
c) Effects of target temperature during IATH
Only one animal study addressed the issue of the effects
of different temperature levels during IATH on out-
comes [28]. This study showed that animals suffering
from prolonged VF-arrest had a better survival rate
(87%) when treated with moderate (33°C) rather than
mild (35°C, 37%, P < 0.001) or severe (30°C, 62%, P =
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0.03) IATH, induced by external ice packs; ROSC rates
were 87%, 37% and 62%, respectively. Moderate IATH
had a higher successful VF termination rate (75%) with
the first defibrillation attempt when compared to mild
(50%) and severe (62%) IATH, although the number of
refibrillation {refibrillation} episodes was similar among
groups. Finally, the number of defibrillation attempts
and the total energy delivered per animal were lower
with deeper hypothermia.
Adverse events
No adverse events associated with IATH were reported
in the animal studies. In a human study of 16 patients
who underwent IATH [15], rapid intravenous adminis-
tration of cold fluids resulted in one case of pulmonary
edema, which resolved after the prompt interruption of
fluid infusion. In the Prince study, TNEC resulted in
transient nasal whitening in 13 of 93 (14%) patients and
epistaxis in three patients (serious in one patient with
an underlying coagulopathy) [16]. Peri-orbital emphy-
sema occurred in one patient and resolved sponta-
neously within 24 hours.
Discussion
This systematic review revealed that: a) in experimental
models of CA, IATH improves survival and neurological
outcome when compared to normothermia and/or
PATH; b) IATH improved ROSC rates and was asso-
ciated with improved cardiac function, including better
left ventricular function and reduced myocardial infarct
size, when compared to normothermia; c) data on the
efficacy of IATH in humans remain limited; d) IATH is
feasible and is associated with few adverse events.
Therapeutic hypothermia has been shown to provide
protective effects on brain and heart cells through differ-
ent pathways. Hypothermic mechanisms providing myo-
cardial protection have not been completely elucidated
but include improved energy production during ische-
mia [38], inhibition of apoptosis [27], increased calcium
sensitivity of myocytes [39], regulation of mitochondrial
oxidative phosphorylation [38], attenuation of reactive
oxygen species generation after ischemia-reperfusion
[40], and preserved myocardial vascular autoregulation
[41]. All these mechanisms translate into increased myo-
cardial contractility [39,42], which should potentially be
enhanced by IATH. Animal studies demonstrated a sig-
nificant improvement in contractility when IATH was
used in comparison with normothermia and PATH
[13,27,30,31] and IATH also had the potential to reduce
the infarction size after coronary vessel occlusion and
CA [13]. Nevertheless, conflicting results have been
reported between IATH and normothermia and/or
PATH in terms of ROSC rate, duration of CPR, CoPP,
total dose of epinephrine administered during CPR and
defibrillation success rate [6,11,12,21,31]. Variations in
the experimental models could explain, at least in part,
these differences. A very short ischemic period is unli-
kely to produce sufficient cardiovascular alteration to
make it possible to demonstrate any superiority of
IATH over other therapies. In one study, time from
CPR to ROSC was as short as two to three minutes [8]
and in another, all the animals achieved ROSC within
one minute after CPR was initiated [23]. The complexity
and severity of the animal model, the different durations
of VF, and the methods used to induce IATH (for
example, systemic vs. selective brain) may also confound
comparison of these studies. A further concern is related
to the limited numbers of experimental animals used, as
sometimes this restricted the power of statistical ana-
lyses [35]. Unfortunately, human studies have reported
only data on the ROSC rate; in the RCT, TNEC resulted
in similar ROSC rates to those seen in the control group
[16], whereas in a retrospective study, IATH using cold
fluids was associated with a significantly increased rate
of ROSC compared to historical controls [18]. Further
studies are needed to investigate myocardial function
during IATH after human CA.
Therapeutic hypothermia may also preserve cerebral
function after CA through inhibition of release of neu-
rotransmitters, such as glutamate and dopamine,
involved in brain damage [43]; preservation of the blood
brain barrier [44]; protection of cerebral energy stores
[45] and microcirculation [46]; and decrease in intracra-
nial pressure and increase in CBF [47]. Importantly, cer-
ebral reperfusion occurring after ROSC can also trigger
the production of free radicals and other neurotoxic
mediators, which may enhance anoxic damage to the
brain [48]. Thus, the beneficial effects of therapeutic
hypothermia after CA should be even more pronounced
when cooling is initiated during the no-flow state and/
or CPR before reperfusion. The positive effects of IATH
on neurological outcome after experimental CA have
been well-demonstrated. IATH affects brain perfusion
and metabolism, as demonstrated by increased supra-
and infra-tentorial CBF [23,33,34] and decreased cere-
bral oxygen uptake [25,33,34], thus preventing anaerobic
metabolism and excito-toxicity [25]. All the experimen-
tal studies showed better neurological function in ani-
mals treated with IATH compared to normothermia or
PATH, as well as a reduction in the number of injured
neurons on histological brain examination. In the
human RCT, IATH increased the intact neurological
outcome rate, particularly in patients with a short no-
flow time [16].
The combination of these beneficial effects of IATH
on cardiac and cerebral functions should be expected to
improve overall survival. However, IATH reduced mor-
tality rates in only 7 of the 16 animal studies in which it
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was compared to normothermia [8,27-32] and 2 of the 6
studies in which it was compared to PATH [8,13].
Nevertheless, some of the negative studies had metho-
dological limitations reducing the possibility of demon-
strating any beneficial effects of IATH over standard
treatment. In two of the studies, the observation period
after CA was less than three hours [10,22], so that no
effects on long-term outcome could be reported. In two
studies, all animals survived after arrest because of a
short no-flow and CPR period [23,24], this situation
being far different from the clinical scenario of CA in
humans. Two studies showed an improvement, although
not statistically significant, in survival rate when IATH
was used [26,35] and the authors acknowledged a lim-
ited sample size as the main reason for their findings.
Human data on the effects of IATH on mortality after
CA are also scarce. External cranial cooling did not
improve survival rates in OHCA compared to a control
group without ice [19]; however, the reduction in tym-
panic temperature, a surrogate of brain temperature,
was similar between groups. In a large retrospective
database, intra-arrest cold intravenous fluids were not
associated with increased overall survival; importantly,
only 13% of the whole cohort received in-hospital thera-
peutic hypothermia. In the RCT using intra-arrest cool-
ing [16], OHCA patients admitted to the hospital and
receiving IATH had improved overall survival when
compared to the control group although the difference
was not statistically significant; these effects appeared to
be even more beneficial in the sub-groups of patients
with short no-flow time and VF.
If IATH is to be applied, it remains unclear which
technique/device provides optimal cooling and protec-
tion. Speed of achieving target temperature in experi-
mental studies was dependent on animal size and the
duration of exposure to hypothermia during CA. These
factors may limit the reproducibility of these data in the
human setting. Moreover, although the neuroprotective
effect of IATH may be related to how quickly the brain
is cooled, systemic cooling is important for myocardial
protection. Also, IATH using cold fluids resulted in a
lower CoPP and decreased LVEF after CA [13]; the
need for epinephrine and duration of CPR were also sig-
nificantly longer than control animals, suggesting that
post-ROSC myocardial dysfunction could be exacerbated
by cold fluid loading. Cooling with an intravascular
catheter, PFC-TLV or TNEC has been shown to
improve ROSC rate, survival and intact neurological
outcome when compared to cold fluid infusion
[10,13,37]. Hence, although intravenous cold fluids have
been shown to be effective and safe when applied after
ROSC [2,14], the safety of large amounts of fluid during
CPR may be questioned.
Other potential methods for IATH induction also have
limitations when applied to the human setting. Internal
cooling with catheters is invasive and not applicable in
the field. Intrapulmonary PFC with TLV would not be
easy to apply and may potentially exacerbate lung injury
because of increased intrapulmonary pressure during
ventilation [10,49]. Trans-nasal cooling devices spray a
PFC fluid through a nasal catheter system into the nasal
cavity and induce brain hypothermia via the cooled blood
and by direct convection; body cooling occurs later.
Further studies are needed to investigate the beneficial
effects of this technique in the human setting as well as
the occurrence of adverse events.
Conclusion
The use of hypothermia has been associated with
improved outcomes for survivors from CA; however, it
has been suggested that the timing of the induced cool-
ing may influence its beneficial effects. Experimental
studies have shown that IATH can protect the heart
against the ischemic processes occurring after CA and
reduce the neuronal injury secondary to global ischemia.
These beneficial effects seem to be significant when
IATH is compared not only to normothermia, but also
to PATH. Nevertheless, not all of these studies have
reported similar conclusions, probably because of the
different experimental conditions that have been used.
Also, the evidence that IATH is superior to PATH in
animal studies is more limited than the evidence com-
paring IATH to normothermia. Human data on IATH
remain limited; however, several large cohort studies
have suggested some beneficial effects of IATH on
ROSC rates and neurological outcomes, especially if
initiated within a short no-flow time. Selective brain
cooling may have potential advantages in protecting the
brain before reperfusion and has shown promising
results in experimental and clinical studies; however,
this technique may limit potentially beneficial effects of
hypothermia on cardiac function and needs to be
further evaluated in the human setting.
Key messages
- IATH improves survival and neurological outcome
when compared to normothermia and/or PATH in
experimental models of CA.
- IATH prevents the decrease in cardiac function
occurring after CA and maintains better cerebral
perfusion and metabolism during CPR when com-
pared to normothermia.
- Data on the efficacy of IATH in humans are still
limited. One RCT showed better survival and neuro-
logical outcome in those patients receiving IATH
with a no-flow time less than 10 minutes. Ongoing
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clinical trials will provide further data on the use of
IATH in human CA.
- In the clinical setting, external cranial cooling, cold
intravenous fluids and TNEC have been used to
induce IATH. Few adverse events have been
reported with these techniques.
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